Pharma R&D & Biobank Services
Oncology Drug Development
Pre-clinicalActive
Key Facts
About Encapsulate
Encapsulate is a private, pre-revenue diagnostics company founded in 2021 and headquartered in San Diego, CA, USA. It has developed an automated 'tumor-on-a-chip' platform that creates microtumors from patient biopsies to functionally test drug responses, aiming to personalize cancer therapy selection. The company has secured significant non-dilutive grant funding from NASA and the NSF, closed an oversubscribed $1.8M seed round, and is actively engaged in research, including unique microgravity studies on the International Space Station. Its primary business model is providing diagnostic testing services to oncologists and collaborative R&D services to pharma.
View full company profileTherapeutic Areas
Other Oncology Drug Development Drugs
| Drug | Company | Phase |
|---|---|---|
| Precision Pharma PTRS Platform | Cellworks | Commercial/Service |
| Pharma R&D Partnership & Biomarker Discovery | Known Medicine | Pre-clinical |
| Therapeutics Development | Resolve Biosciences | Research-Use |